| Name | Succinyl coenzyme A sodium salt | 
|---|---|
| Synonyms | 4-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-[hydroxy(oxido)phosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-4-oxobutanoate | 
| Description | Succinyl-Coenzyme A (Succinyl-CoA) sodium is an intermediate of the citric acid cycle. Succinyl-Coenzyme A sodium can be converted to succinic acid and can also combines with glycine to form δ-ALA to synthesize porphyrins (heme). Succinyl-Coenzyme A sodium can be used in the study of metabolic, neurological and haematological abnormalities (such as porphyrias) caused by nutritional vitamin B12 deficiency (resulting in a deficiency in Succinyl-Coenzyme A synthesis)[1][2]. | 
|---|---|
| Related Catalog | 
| Molecular Formula | C25H38N7O19P3S | 
|---|---|
| Molecular Weight | 865.59100 | 
| Exact Mass | 865.11600 | 
| PSA | 468.30000 | 
| Storage condition | 20°C | 
| Symbol |   GHS07 | 
|---|---|
| Signal Word | Warning | 
| Hazard Statements | H315-H319-H335 | 
| Precautionary Statements | P280-P305 + P351 + P338-P337 + P313 | 
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves | 
| Hazard Codes | Xi: Irritant; | 
| Risk Phrases | 36/37/38 | 
| Safety Phrases | 22-26-36 | 
| RIDADR | NONH for all modes of transport |